135 related articles for article (PubMed ID: 18672373)
21. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
22. Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.
Padrissa-Altés S; Franco-Gou R; Boillot O; Serafín A; Rimola A; Arroyo V; Rodés J; Peralta C; Roselló-Catafau J
Liver Transpl; 2009 Mar; 15(3):313-20. PubMed ID: 19242996
[TBL] [Abstract][Full Text] [Related]
23. 4-benzyl-3-phenyl-5H-furan-2-one, a vasodilator isolated from Malbranchea filamentosa IFM 41300.
Hosoe T; Iizuka T; Komai S; Wakana D; Itabashi T; Nozawa K; Fukushima K; Kawai K
Phytochemistry; 2005 Dec; 66(23):2776-9. PubMed ID: 16213536
[TBL] [Abstract][Full Text] [Related]
24. The role of angiotensin II in hypertension and end-organ damage.
Pool JL
Int J Clin Pract Suppl; 2000 Aug; (111):4-8. PubMed ID: 15977400
[TBL] [Abstract][Full Text] [Related]
25. Novel paramagnetic AT1 receptor antagonists.
Tan NP; Taylor MK; Bottle SE; Wright CE; Ziogas J; White JM; Schiesser CH; Jani NV
Chem Commun (Camb); 2011 Nov; 47(44):12083-5. PubMed ID: 21963998
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analogues.
Mavromoustakos T; Moutevelis-Minakakis P; Kokotos CG; Kontogianni P; Politi A; Zoumpoulakis P; Findlay J; Cox A; Balmforth A; Zoga A; Iliodromitis E
Bioorg Med Chem; 2006 Jul; 14(13):4353-60. PubMed ID: 16546395
[TBL] [Abstract][Full Text] [Related]
27. Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII.
Calderone V; Giorgi I; Livi O; Martinotti E; Mantuano E; Martelli A; Nardi A
Eur J Med Chem; 2005 Jun; 40(6):521-8. PubMed ID: 15922836
[TBL] [Abstract][Full Text] [Related]
28. [Effects of sapindoside on blood pressure and vasoactive substance in renovascular hypertension rat].
Wang WS; Long ZJ; Zhang L; Bian H; Wang L; Chen M
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1703-5. PubMed ID: 18027673
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
[TBL] [Abstract][Full Text] [Related]
30. An ab initio study of AT2 antagonists.
Jain S; Yadav A
Chem Biol Drug Des; 2008 Mar; 71(3):271-7. PubMed ID: 18248348
[TBL] [Abstract][Full Text] [Related]
31. Citrus limetta leaves extract antagonizes the hypertensive effect of angiotensin II.
Perez YY; Jimenez-Ferrer E; Alonso D; Botello-Amaro CA; Zamilpa A
J Ethnopharmacol; 2010 Apr; 128(3):611-4. PubMed ID: 20149855
[TBL] [Abstract][Full Text] [Related]
32. Vascular angiotensin AT2 receptors in hypertension and ageing.
Widdop RE; Vinh A; Henrion D; Jones ES
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):386-90. PubMed ID: 18307726
[TBL] [Abstract][Full Text] [Related]
33. Selenosartans: novel selenophene analogues of milfasartan and eprosartan.
Grange RL; Ziogas J; North AJ; Angus JA; Schiesser CH
Bioorg Med Chem Lett; 2008 Feb; 18(3):1241-4. PubMed ID: 18191398
[TBL] [Abstract][Full Text] [Related]
34. Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.
Van Liefde I; Vauquelin G
Mol Cell Endocrinol; 2009 Apr; 302(2):237-43. PubMed ID: 18620019
[TBL] [Abstract][Full Text] [Related]
35. Blood pressure lowering in acute ischaemic stroke: an update on the role of angiotensin receptor blockers.
Sigurdsson ST; Strandgaard S
J Hypertens; 2007 Apr; 25(4):743-5. PubMed ID: 17351363
[No Abstract] [Full Text] [Related]
36. Acaricidal activity and function of mite indicator using plumbagin and its derivatives isolated from Diospyros kaki Thunb. roots (Ebenaceae).
Lee CH; Lee HS
J Microbiol Biotechnol; 2008 Feb; 18(2):314-21. PubMed ID: 18309277
[TBL] [Abstract][Full Text] [Related]
37. Two new 5-hydroxy-2-pyrone derivatives isolated from a marine-derived fungus Aspergillus flavus.
Lin A; Lu X; Fang Y; Zhu T; Gu Q; Zhu W
J Antibiot (Tokyo); 2008 Apr; 61(4):245-9. PubMed ID: 18503205
[TBL] [Abstract][Full Text] [Related]
38. Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells.
Tomlinson ID; Mason JN; Blakely RD; Rosenthal SJ
Methods Mol Biol; 2005; 303():51-60. PubMed ID: 15923674
[TBL] [Abstract][Full Text] [Related]
39. Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
Mavromoustakos T; Zervou M; Zoumpoulakis P; Kyrikou I; Benetis NP; Polevaya L; Roumelioti P; Giatas N; Zoga A; Minakakis PM; Kolocouris A; Vlahakos D; Grdadolnik SG; Matsoukas J
Curr Top Med Chem; 2004; 4(4):385-401. PubMed ID: 14965308
[TBL] [Abstract][Full Text] [Related]
40. Ab initio study of non-peptidic antihypertensives.
Jain S; Yadav A
Chem Biol Drug Des; 2007 Apr; 69(4):251-7. PubMed ID: 17461972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
